ANXA5 and B-cell chronic lymphocytic leukemia: An initial study on the impact of XN on lymphocytes from patients with B-chronic lymphocytic leukemia (B-CLL) showed that XN induced the dose-dependent killing of B-CLL cells, which was associated with annexin V positivity and, thus, suggested an apoptotic mechanism of this cell death [67].